A staged approach using preprocedural pulmonary hypertension drugs and a customized fenestrated occluder device can enable successful ASD closure in high-risk patients with suprasystemic pulmonary pressure and small left ventricle.
No takes yet. Share an insight, caveat, or question.
May support staged ASD closure in select high-risk PH patients; hypothesis-generating and requires prospective validation before practice change.
Tal et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: